Category Archives: Pharmaceuticals

Investors shell out $619M in huge health-sector IPO stampede.

The News: Four biotechs and a genome-sequencing player firm grabbed their brass rings last week, cashing in with $619 million in total IPO funding. That means that with one week… Read more »

Medical Stock Spotlight: Three winners from last week hit with profit-taking, while one big loser rebounds. This week, Provention shines, but Cymabay bombs.

Stocks continue to be whipsawed by sudden upward, then plunging, prices, only to reverse direction again as political and economic uncertainty reigns supreme. Here are four prime examples of this… Read more »

The worldwide battle over health spending, especially high drug prices, and whether it’s actually worth it. The view from afar.

Commentary: Steve Walker The “Medicare for All” plan embraced by leading 2020 Democrats looks more lavish than what other advanced countries offer, compounding the cost but also potentially broadening its… Read more »

Healthcare stocks rattled by Trump’s threat to force public pricing disclosure across the entire sector. The top winners, losers, and reasons why.

President Trump is expected to sign an executive order this week that would require for the first time disclosure of prices across the healthcare industry, in a move that officials… Read more »

Medical stocks resemble Mr. Toad’s Wild Ride with brave investors tightening their seat belts and neck braces for more uncertainty, price fluctuation.

Health-sector stocks were whipsawed upward, downward, backward and forward last week, rekindling memories of the Yardbirds’ hit song in the 60’s with a similar name. Still, when the dust settled,… Read more »

Close (but not too close) encounters with God confer mental health benefits, say researchers at Johns Hopkins. This definitely isn’t your typical medical article.

The News: Profound religious experiences are linked to lasting mental health benefits, new research suggests. In a survey study of more than 4000 individuals, those who reported having profound personal… Read more »

Seven health-sector IPOs do the limbo and raise $499M, seconds before market falls off a cliff.

Trade war fears are crushing stocks, and the their swan dive onto the rocks could keep going if Presidents Trump and China’s Xi Jinping keep tossing tariff grenades at each… Read more »